Chemotherapy Use, Performance Status, and Quality of Life at the End of Life (Q36790047)

16 August 2017

Chemotherapy Use, Performance Status, and Quality of Life at the End of Life (English)

1 reference

16 August 2017

1 reference

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26203912%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Melissa M Garrido

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26203912%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

8

M Carrington Reid

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26203912%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

6

Bryan J Schneider

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26203912%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

author name string

Holly G Prigerson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26203912%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Yuhua Bao

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26203912%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Manish A Shah

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26203912%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

M Elizabeth Paulk

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26203912%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

David A Berlin

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26203912%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Kerin B Adelson

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26203912%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Alfred I Neugut

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26203912%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Paul K Maciejewski

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26203912%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

publication date

23 July 2015

1 reference

16 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26203912%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26203912%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26203912%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

page(s)

778-784

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26203912%20AND%20SRC:MED&resulttype=core&format=json

Generalizability of trial results to elderly Medicare patients with advanced solid tumors (Alliance 70802).

14 June 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828728

Associations between palliative chemotherapy and adult cancer patients' end of life care and place of death: prospective cohort study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828728

The influence of patients' quality of life at the end of life on bereaved caregivers' suicidal ideation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828728

Change in end-of-life care for Medicare beneficiaries: site of death, place of care, and health care transitions in 2000, 2005, and 2009

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828728

Factors important to patients' quality of life at the end of life

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828728

Survival among non-small cell lung cancer patients with poor performance status after first line chemotherapy.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828728

American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828728

The effect on survival of continuing chemotherapy to near death

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828728

Survival outcomes for patients with metastatic triple-negative breast cancer: implications for clinical practice and trial design

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828728

Treating in the dark: unanswered questions on costs and benefits of late line therapy for metastatic breast cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828728

Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828728

A retrospective analysis of the outcome of patients who have received two prior chemotherapy regimens including platinum and docetaxel for recurrent non-small-cell lung cancer.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828728

Toxicity and response criteria of the Eastern Cooperative Oncology Group

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828728

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828728

'I don't want Jenny to think i'm abandoning her': views on overtreatment.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828728

A Short Portable Mental Status Questionnaire for the Assessment of Organic Brain Deficit in Elderly Patients†

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828728

Characterization of patients receiving palliative chemo- and radiotherapy during end of life at a regional cancer center in Norway

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828728

Effect of early palliative care on chemotherapy use and end-of-life care in patients with metastatic non-small-cell lung cancer.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828728

Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828728

Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828728

Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828728

Trends in the aggressiveness of cancer care near the end of life

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828728

Chemotherapy Use among Medicare Beneficiaries at the End of Life

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828728

Prognostic factors for survival in patients with inoperable lung cancer.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828728

Nonanatomic prognostic factors in carcinoma of the lung: a multivariate analysis

5 September 2018

1 reference

12 December 2020

Delivering maximum clinical benefit at an affordable price: engaging stakeholders in cancer care

1 reference

12 December 2020

Resurrecting treatment histories of dead patients: a study design that should be laid to rest

1 reference

12 December 2020

Why do our patients get chemotherapy until the end of life?

1 reference

12 December 2020

10.1001/JAMAONCOL.2015.2378

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26203912%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26203912%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

PubMed publication ID

26203912

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26203912%20AND%20SRC:MED&resulttype=core&format=json